We review the cardiac safety of the drugs available at present for the maintenance treatment
of chronic obstructive pulmonary disease (COPD) in stable disease, focusing on inhaled …

Guidelines for the treatment of chronic obstructive pulmonary disease (COPD) have
consistently recommended long-acting inhaled bronchodilators—either long-acting …

In this guideline update, we highlight important and new findings related to pharmacological
therapy of chronic obstructive pulmonary disease (COPD) that should change clinical …

Chronic obstructive pulmonary disease (COPD) is a readily diagnosable disorder that
responds to treatment. Smoking cessation can reduce symptoms and prevent progression of …

Long-acting muscarinic antagonist (LAMA) or long-acting β2-agonist (LABA) bronchodilators
and their combination are recommended for the maintenance treatment of chronic …

Clinical phenotyping is currently used to guide pharmacological treatment decisions in
chronic obstructive pulmonary disease (COPD), a personalized approach to care. Precision …

Background: This document provides clinical recommendations for the pharmacologic
treatment of chronic obstructive pulmonary disease (COPD). It represents a collaborative …

Although the development of effective treatments for patients with chronic obstructive
pulmonary disease (COPD) has not been seen as a high priority, the past decade has seen …

Bronchodilators, corticosteroids, and antibiotics are still key elements for treating chronic
obstructive pulmonary disease in the 2019 Global Initiative for Chronic Obstructive Lung …

The Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy document for the
treatment of chronic obstructive pulmonary disease (COPD) suggests that, after …